SLC31A1 and glioblastoma: Notably, increased expression of SLC31A1 in GBM has been associated with reduced patient survival, whereas downregulation of SLC31A1 can impede the proliferation, migration, and invasion of GBM cells, thereby promoting a tumor-suppressive microenvironment [38].